Back
22
Day Range
$3.30
$3.30
52-Week Range
$1.99
$3.69
Volume
2,857
50D / 200D Avg
$3.21
/
$2.92
Prev Close
$3.30
Price History
Financial Trends
Peer Comparison
vs Consumer Cyclical sector median (609 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 1.2 | 11.1 |
| P/B | 0.3 | 1.4 |
| ROE % | 24.8 | 10.7 |
| Net Margin % | 2.6 | 5.1 |
| Rev Growth 5Y % | 12.2 | 8.3 |
| D/E | 7.4 | 0.8 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$7.24
$6.83 – $7.86
|
120 B | 1 |
| FY2028 |
$6.13
$5.78 – $6.65
|
100 B | 1 |
| FY2027 |
$4.81
$4.54 – $5.22
|
97 B | 1 |
Key Takeaways
Revenue grew 12.20% annually over 5 years — strong growth
Earnings grew 190.51% over the past year
ROE of 24.75% indicates high profitability
Debt/Equity of 7.36 — high leverage
Generating 5.53B in free cash flow
P/E of 1.18 — trading at a low valuation
Growth
Revenue Growth (5Y)
12.20%
Revenue (1Y)7.09%
Earnings (1Y)190.51%
FCF Growth (3Y)-26.23%
Quality
Return on Equity
24.75%
ROIC8.17%
Net Margin2.64%
Op. Margin9.41%
Safety
Debt / Equity
7.36
Current Ratio0.36
Interest Coverage1.73
Valuation
P/E Ratio
1.18
P/B Ratio0.30
EV/EBITDA7.70
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.09% | Revenue Growth (3Y) | 5.34% |
| Earnings Growth (1Y) | 190.51% | Earnings Growth (3Y) | -13.53% |
| Revenue Growth (5Y) | 12.20% | Earnings Growth (5Y) | 32.01% |
| Profitability | |||
| Revenue (TTM) | 84.59B | Net Income (TTM) | 2.23B |
| ROE | 24.75% | ROA | 2.77% |
| Gross Margin | 67.59% | Operating Margin | 9.41% |
| Net Margin | 2.64% | Free Cash Flow (TTM) | 5.53B |
| ROIC | 8.17% | FCF Growth (3Y) | -26.23% |
| Safety | |||
| Debt / Equity | 7.36 | Current Ratio | 0.36 |
| Interest Coverage | 1.73 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 1.18 | P/B Ratio | 0.30 |
| P/S Ratio | 0.03 | PEG Ratio | 0.10 |
| EV/EBITDA | 7.70 | Dividend Yield | 0.01% |
| Market Cap | 2.64B | Enterprise Value | 61.30B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 84.59B | 78.99B | 76.23B | 68.83B | 53.38B |
| Net Income | 2.23B | 767.58M | 2.98B | 1.74B | 734.19M |
| EPS (Diluted) | 2.70 | 0.94 | 3.66 | 2.07 | 0.88 |
| Gross Profit | 57.17B | 53.64B | 46.85B | 45.51B | 36.10B |
| Operating Income | 7.96B | 8.28B | 8.03B | 6.37B | 4.13B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 80.56B | 83.81B | 77.43B | 78.46B | 82.98B |
| Total Liabilities | 71.79B | 74.42B | 67.84B | 69.63B | 74.30B |
| Shareholders' Equity | 8.74B | 9.28B | 8.66B | 8.34B | 8.07B |
| Total Debt | 64.35B | 50.32B | 46.04B | 49.61B | 55.49B |
| Cash & Equivalents | 5.69B | 6.47B | 6.41B | 6.09B | 6.89B |
| Current Assets | 12.53B | 15.20B | 13.01B | 12.13B | 11.65B |
| Current Liabilities | 34.33B | 27.19B | 23.15B | 21.54B | 19.64B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#394 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026